GlassScriptPhysician profile
Stacy Serebnitsky
NPI 1336379817
$1,454.45
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $588 · 2021: $91.56 · 2022: $92.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $216.58 | 2019 | |
| Scilex Pharmaceuticals INC. | $202.32 | 2019-2022 | |
| Pacira Therapeutics, INC. | $146.87 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $121.30 | 2019-2020 | |
| Abbvie INC. | $109.04 | 2020-2022 | |
| Redhill Biopharma INC. | $80.33 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.06 | 2019-2020 | |
| Pfizer INC. | $71.65 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $58.61 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $55.06 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $53.00 | 2019-2020 | |
| Si-Bone, INC. | $36.35 | 2019 | |
| Depuy Synthes Sales INC. | $29.75 | 2019-2020 | |
| Virtus Pharmaceuticals LLC | $29.24 | 2020 | |
| Arbor Pharmaceuticals, INC. | $28.84 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $28.16 | 2021 | |
| Amgen INC. | $20.74 | 2019 | |
| Horizon Therapeutics Plc | $19.93 | 2020 | |
| Alfasigma USA, INC. | $19.55 | 2020 | |
| Boston Scientific Corporation | $19.34 | 2020 | |
| Medtronic USA, INC. | $16.67 | 2019 | |
| Lilly USA, LLC | $14.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Serebnitsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.